Background and Objectives. The purpose of this study was to investigate whe
ther 5% ketamine with and without preservative, administered intrathecally
to swine, produced a clinical anesthetic effect and caused direct subacute
neurotoxicity. Methods. Twenty pigs were used. Under general anesthesia, a
subarachnoid catheter was placed at L5-L6 or L6-S1 spinal interspace. Five
animals were used for initial clinical evaluation of the anesthetic effects
of subarachnoid ketamine (12.5 and 25.0, and 500 mg). Two animals were exc
luded because of bloody taps, two served as controls (catheterization witho
ut drug administration), four received ketamine racemate (25.0 mg/d), four
received ketamine racemate preservative free (25.0 mg/d), and three receive
d benzethonium chloride, the ketamine excipient (0.05 mg/d). All drugs were
administered for 7 days. The catheters were withdrawn at the end of the tr
eatment period. Alter 35 days, the pigs were euthanized and the spinal cord
removed and preserved for histopathologic study with hematoxilyn-eosin and
luxol-fast blue myelin staining. Histopathologic effects were defined as a
bsent/minimal mild. or severe by a pathologist, unaware of group allocation
, by evaluating the presence and intensity of peripheral and/or central chr
omatolysis, spongiosis, neuronal loss, perivascular neuroglia, neuronolysis
, and myelin degeneration. Results. All doses of ketamine produced immediat
e cutaneous anesthesia and motor block; benzethonium chloride did not. Hist
opathologic examination showed no neurotoxic effect of ketamine without pre
servative; ketamine with preservative showed a discrete neurotoxic effect,
and the preservative alone produced a moderate neurotoxic effect. Conclusio
ns. Clinically, in swine, subarachnoid ketamine without preservative is a s
afe and effective anesthetic and did not show significant neurotoxic effect
s. However, ketamine with preservative produces minimal changes, and benzet
honium chloride alone produces moderate neurotoxic effects.